Genome Canada is very pleased to announce the appointment of Mr. Marc LePage as the new President and CEO of Genome Canada, starting January 4, 2016.
Mr. LePage has deep roots within the Canadian genomics community and a track record of success in advancing genomics in Canada. His regional, national and international experience, coupled with exceptional fundraising and communication skills make him extremely well qualified to lead Genome Canada into its next phase of growth.
Mr. LePage was one of the pioneers behind the founding of Genome Canada in 2000. During his tenure as Executive Vice-President of Corporate Development, he made key contributions to the rapid ramp up the organization, its programs and peer review system. Today, his leadership of the organization will be critical in shaping the future of genomics in Canada and helping our nation realize the full potential of this cutting-edge field of science and technology for the benefit of all Canadians.
The appointment of Mr. LePage follows an exhaustive national and international executive search led by a special sub-committee of the Board.